US · biotechnology · gene therapy

Who invested in Latus Bio

One round we have observed, with the investors the report named. Every figure below came from a named source, and where the company reported the raise to the SEC itself, that is shown beside it.

1
rounds observed
3
investors named
$97M
reported across those rounds
May 2026
most recent

The rounds

Series A · May 2026 · $97M

8VC lead, DCVC Bio lead, CHOP

Reported by Ventureburn

Everyone who backed them

InvestorTypeRounds
VC firm1
Investment firm1

Missing a round, or an investor who was in one? Tell us.